Research Areas
- Cardiovascular diseases, heart failure, diabetes, and inflammation
- Stem cells & regenerative medicine
- Congenital heart disease
- Multiomics and bioinformatics
Scientific Achievements
- Establish inflammatory heart disorders biorepository in Hawaii for multiomics research.
- Develop a genomic methylation reporter model visualizing stem cell differentiation and cell cycle.
- Improve AI/ML-readiness for multiomics data in congenital heart disease research
Funding
RCMI Funding: U24MD015970-0551, NIH/NIMHD: CRPPP “Cellular and Genetic Mechanisms of Inflammatory Heart Disease”
Other funding obtained with RCMI support: U54MD007601, NIH/NIMHD/OD: Administrative Supplements “Processing Multiomic Datasets for Improved AI/ML-readiness in Congenital Heart Disease”
Other funding obtained with RCMI support: U54MD007601, NIH/NIMHD/OD: Administrative Supplements “Processing Multiomic Datasets for Improved AI/ML-readiness in Congenital Heart Disease”
Scientific Advance
Dynamic visualization of DNA methylation in cell cycle genes during iPSC cardiac differentiation
Published in Epigenomics, 2024; Vol 16; PMCID: PMC11622782
Published in Epigenomics, 2024; Vol 16; PMCID: PMC11622782
Epigenetic DNA modification involves a temporary chemical change - often by attaching a methyl group to a DNA base chemical – which can activate or silence a gene without permanently altering the genetic DNA composition. This is a crucial molecular process that regulates the structure and function of human cells during development, growth and disease. Our team used bioluminescent tags to visualize dynamic changes in genomic DNA methylation and track cell development in living cells over time. We specifically examined epigenetic DNA modification during the differentiation of stem cells into cardiac cells. This knowledge will help us identify how specific drugs (including those taken during pregnancy) can lead to cardiac abnormalities in children.
NIH/NIMHD # U54MD007601
